Historical

EP07-A

Interference Testing in Clinical Chemistry; Proposed Guideline

Intended to promote uniformity in the evaluation of interference characteristics of clinical laboratory methods. EP7 describes procedures for manufacturers to screen potentially interfering substances, to quantify interference effects, and to confirm interference in patient samples. This document also describes procedures for clinical laboratories to verify interference claims, and to investigate discrepant results caused by unsuspected interfering substances. Detailed examples are given. EP7 also contains background information on interference testing concepts, tables of recommended test concentrations for analytes and potential interference, and data collection and analysis worksheets. FDA

CONTENT PROVIDER
Clinical And Laboratory Standards Institute [clsi]

Others Also Bought
Preliminary Evaluation of Quantitative Clinical Laboratory Methods; Approved Guideline - Second Edition
Included in Packages
This standard is not included in any packages.
Document History
We have no document history for this standard.
Amendments & Corrections
We have no amendments or corrections for this standard.